EP1750659A1 - Wachmischung auf basis von partialglyceriden und pentaerythritestern - Google Patents

Wachmischung auf basis von partialglyceriden und pentaerythritestern

Info

Publication number
EP1750659A1
EP1750659A1 EP05716400A EP05716400A EP1750659A1 EP 1750659 A1 EP1750659 A1 EP 1750659A1 EP 05716400 A EP05716400 A EP 05716400A EP 05716400 A EP05716400 A EP 05716400A EP 1750659 A1 EP1750659 A1 EP 1750659A1
Authority
EP
European Patent Office
Prior art keywords
weight
self
wax
mixture
wax mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05716400A
Other languages
German (de)
English (en)
French (fr)
Inventor
Caroline Goget
Ulrich Issberner
Rolf Kawa
Catherine Mitchell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cognis IP Management GmbH
Original Assignee
Cognis IP Management GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102004017222A external-priority patent/DE102004017222A1/de
Priority claimed from DE200410031939 external-priority patent/DE102004031939A1/de
Application filed by Cognis IP Management GmbH filed Critical Cognis IP Management GmbH
Publication of EP1750659A1 publication Critical patent/EP1750659A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/31—Anhydrous

Definitions

  • the invention relates to wax mixtures of partial glyecrides and esters of pentaerythritol or oligomers of pentaerythritol and self-emulsifying mixtures based on the wax mixtures.
  • the invention also relates to compositions based on the self-emulsifying mixtures.
  • Wax-based formulations have long been known to the person skilled in the art. These are among others used for cosmetic and pharmaceutical formulations, e.g. Suppositories, various cosmetic compositions in stick form or in creams and lotions, for coating papers and textiles, etc. Numerous wax-like substances and substance mixtures are available to the person skilled in the art. These include, for example, glycerides and fatty alcohols, which have a decisive impact on the sensor technology of the final formulations. Glycerides leave an often oily / greasy skin feeling. Fatty alcohols lead to a stronger white residue formation, which is perceived by users as very disadvantageous. In addition, fatty alcohols often lead to excessive viscosity increases during storage.
  • Waxes and wax combinations are also used, among other things, to favorably influence the consistency and viscosity of cosmetic formulations.
  • the viscosity of cosmetic emulsions in particular oil in water (O / W) emulsions, is generally adjusted using so-called hydrophilic waxes. This is understood to mean substances or mixtures of substances that have a melting point above 30 ° C and have free OH groups in the molecule that can interact with water (hydrate formation through hydrogen bonding) and thus through the formation of so-called lamellar phases make a significant contribution to the increase in viscosity in O / W emulsions.
  • the viscosity not only influences the phase stability, but also has a clearly positive effect on essential sensory parameters, which include “cushion”, “distribution” and “peaking”.
  • the cosmetic chemist uses waxes of this type to form emulsions with regard to sensors and viscosity
  • the disadvantage is that lamellar phases are not resistant to aging and the viscosities depend on the time can fall or rise, which ultimately changes the sensor system.
  • DE 31 31 006 A1 a solution to the problem of achieving stable viscosities was shown with a precisely coordinated wax combination of partial glycerides, fatty alcohols, wax esters and triglycerides, but as the document describes, it always fails when the specified quantitative ratios vary slightly become.
  • the object of the present invention was to provide combinations of known hydrophilic waxes which, in a wide mixture ratio, ensure long-term stable viscosities of O / W emulsions, regardless of the structure of the emulsifiers used and the polarity of the emollients used.
  • the invention therefore relates to an anhydrous wax mixture
  • an anhydrous wax mixture comprising as component (a) at least one ester of pentaerythritol, dipentaerythritol, tripentaerythritol or any mixture of these esters and as component (b) at least one partial glyceride, the weight ratio of (a) to (b ) from 1: 3 to 3: 1.
  • Anhydrous for the purposes of the invention are wax mixtures which contain less than 2% by weight of water, preferably less than 1% by weight of water, particularly preferably less than 0.5% by weight of water and in particular less than 0.1 Wt .-% water.
  • the wax mixtures usually only contain residual amounts of water due to the raw material.
  • O / W emulsions which contain the wax mixtures according to the invention not only show “stable” viscosity values over several weeks, but that the viscosities of the emulsions are significantly higher than viscosities obtained when using the same amount of a single wax component
  • the viscosity build-up in emulsions based on the wax mixtures according to the invention is independent of the polarity of the oils used and also independent of the structure of the emulsifiers used.
  • the wax mixtures according to the invention allow the cosmetic chemist, sensors and viscosity to coordinate exactly with each other, without running the risk that the temporal changes in viscosity also negatively affect the sensory properties.
  • component (a) According to the invention, preferred are wax mixtures which are characterized in that component (a) is selected from the group of the C6-C22 fatty acid esters of pentaerythritol, dipentaerythritol, tripentaerythritol or any mixture of these esters, some of which Have a melting point of at least 30 ° C.
  • the esters can have a single type of fatty acid acyl group or a mixture of different fatty acid acyl groups, the fatty acids can be branched or unbranched and / or saturated or unsaturated. Preferably be used for esterification used with a high content of saturated unbranched fatty acids, especially those that come from vegetable raw material sources. C14-C24 fatty acids, in particular C14-C20 fatty acids, are preferred according to the invention.
  • a further preferred embodiment of the wax mixture is characterized in that component (a) is selected from the group of the esters of pentaerythritol which have a proportion of (i) 5-35% by weight monoester, (ii) 20-50% by weight. -% diester and (iii) 25-50% by weight triester, and optionally tetraester.
  • a very particularly preferred embodiment of the wax mixture contains as ester component (a) esters of pentaerythritol, dipentaerythritol or tripentaerythritol which contain less than 0.3% by weight of C17 fatty acid acyl groups.
  • a further preferred embodiment of the wax mixture is characterized in that the ester component (a) is obtained by esterification with a fatty acid mixture containing 40-50% by weight of C16 fatty acid and 45-55% by weight of C18 fatty acid.
  • the remaining amounts of the fatty acid mixture are shorter-chain ( ⁇ C14) and longer-chain (> C18) fatty acids.
  • Esters of pentaerythritol and dipentaerythritol with a C16 / C18 fatty acid weight ratio of approx. 0.7 - 0.9 are related to the superior sensory properties.
  • an ester of pentaerythritol is preferred, which is obtained by reacting pentaerythritol with a fatty acid mixture containing 42-48% by weight of C16 fatty acid and 50-56% by weight of C18 fatty acid (remaining amounts: ⁇ C14 fatty acids and> C18 Fatty acids) is obtained and has the following ester distribution: 12-19% by weight monoester, (b) 25-35% by weight diester, (c) 30-40% by weight triester and (d) 6-11% by weight .-% tetraester.
  • per mol pentaerythritol is 1.8 - 2.2 mol of the fatty acid mixture, preferably 1.9 - 2.1 mol, ei ⁇ ggi for the esterification ⁇ .
  • C16 / C18 fatty acid pentaerythritol esters can be carried out by adding 1.8-2.2 mol, preferably 1.9-2.1 mol, of a fatty acid mixture containing 40-50% by weight of C16 fatty acid and 45-55% by weight per 1 mol of pentaerythritol. -% C18 fatty acid or a raw material mixture with a corresponding fatty acid distribution and (a) the esterification at temperatures in the range of
  • a preferred embodiment of the wax mixture is characterized in that the partial glyceride (b) is selected from the group of esterification products from glycerol or oligoglycerol with fatty acids with a chain length of 12 to 24 carbon atoms or any mixture of these esterification products.
  • oligoglycerols are understood to mean oligomers of glycerol with 2-12 glycerol units.
  • the fatty acids which can be used for the esterification include, for example, myristic, pentadecane, palmitic, margarine, stearic, nonadecane, arachine, behenic, lignoceric, cerotinic, melissic, erucic and elaeostearic acids and substituted fatty acids, such as B. 12-hydroxystearic acid, this list being exemplary and not restrictive. It is preferred according to the invention to use fatty acids / fatty acid mixtures which have a high proportion of unbranched, saturated fatty acids.
  • the partial glyceride (b) is preferably a palmitic and / or stearic acid ester of glycerol with a monoglyceride content of 30 to 65% by weight and a diglyceride content of 25 to 45% by weight.
  • a monoglyceride content of at least 30% by weight With a monoglyceride content of at least 30% by weight, the viscosity build-up is ensured particularly well and the final cosmetic formulations are distinguished by improved long-term stability. Up to an upper limit of 65% by weight of monoglyceride, the risk of crystallization is also relatively low.
  • the partial glyceride (b) is preferably obtained by reacting glycerol with a fatty acid mixture of palmitic and stearic acid in a weight ratio of 1: 3 to 3: 1.
  • inventively employable partial glycerides include, for example, by Cognis Germany GmbH & Co. KG marketed products Cutina ® MD (30 - 45 wt .-% Monogylceridanteil - / -. Diglyeeridanteil-35 --- 45% by weight), Cutina ® GMS ( 40-55% by weight monoglyceride / diglyceride 30-45% by weight) and Monomuls 60-35 (55-65% by weight monoglyceride / diglyceride 25-45% by weight).
  • Mixed esters and mixtures of mono-, di- and triglycerides are preferably suitable according to the invention because they show a lower tendency to crystallize and thus improve the performance of the wax mixture according to the invention. They are also much more compatible with oils of different polarities.
  • the wax mixtures according to the invention are usually processed in the formulation of cosmetic or pharmaceutical compositions with oil bodies, water and emulsifiers. From an application point of view, it is particularly advantageous to provide a self-emulsifying base based on the wax mixtures according to the invention which already contains the required amount of emulsifiers.
  • Another object of the invention is therefore self-emulsifying bases containing a wax mixture according to one of claims 1 to 7 and additionally at least one emulsifier (c) selected from the group of anionic or nonionic emulsifiers with an HLB value greater than 10. Between the term emulsifier and According to the invention, surfactant is not differentiated.
  • the structure of the emulsifiers is not particularly critical.
  • HLB values of commercial emulsifiers are known to the person skilled in the art and can be found, for example, in Fiedler, Lexicon of auxiliaries for pharmacy, cosmetics and related areas, Volume 9, 1971, pages 265-270; Kirk-Othmer (3rd edition) volume 8, pages 909-918 and Janistyn (3rd edition) volume 1, page 470; and Volume 3, pages 68-78.
  • the listed there anionic and nonionic Emulgatören "rnit an HLB greater than 10 should be of the present disclosure part.
  • the emulsifiers can be used as active substance or in the form of aqueous solutions.
  • anionic emulsifiers / surfactants that may be used erfindungshack- are soaps , Alkyl benzene sulfonates, alkane sulfonates, _ olefin sulfonates, alkyl ether sulfonates, _ glycerol ether sulfonates, ⁇ -methyl ester sulfonates, sulfo fatty acids, alkyl sulfates, fatty alcohol ether sulfates, glycerin ether sulfates, fatty acid ether sulfates, hydroxymixed ether sulfates, monosulfate sulfate, monoglyate sulfate, sulfate amate sulfate, monoglyate sulfate, sulfate amate sulfate, monoglyate sulfate, sulfate amate sulfate,
  • the group of particularly suitable nonionic emulsifiers / surfactants with an HLB value> 10 includes corresponding compounds which are selected from:
  • Ci2 / i8 fatty acid monoesters and diesters of adducts of ethylene oxide and / or propylene oxide with glycerol (2) Ci2 / i8 fatty acid monoesters and diesters of adducts of ethylene oxide and / or propylene oxide with glycerol.
  • POE. nonylphenol (ether), POE (10) stearyl alcohol (ether), POE (8) tridecyl alcohol (ether), POE (8) lauric acid (monoester), POE (10) cetyl alcohol (ether), acetylated POE (10 ) Lanolin, POE (20) glycerol monostearate, PEG 400 monolaurate, POE (16) lanolin alcohol (ether), POE (4) sorbitan monolaurate, POE (10) nonylphenol (ether), POE (15) long oil fatty acids (ester), POE (10 )
  • Oclylphe1 ⁇ r (ethe 7P- ⁇ 0 " monostearate, tertiary amines: POE fatty amines; POE (24) cholesterol, POE (14) nonylphenol (ether), POE (12) lauryl alcohol, POE (20) sorbitan monostearate, sucrose monolaurate, POE (20) sorbitan Monooleate, acetylated POE (9) lanolin, POE (20) stearyl alcohol, POE (20) oleyl alcohol (ether), PEG 1000 monooleate, POE (20) taigamine, POE (20) sorbitan monopalmitate, POE (20) cetyl alcohol (ether), POE (25) propylene glycol monostearate, POE (20) nonylphenol (ether), PEG (1000) monolaurate, POE (20) sorbitan monolaurate, POE (23) lauryl alcohol (ether), POE (40) stearic acid (monoester),
  • the self-emulsifying bases make it possible to produce viscosity-stable O / W emulsions particularly easily, since the ratio of the emulsifiers to the consistency waxes is already precisely coordinated.
  • a self-emulsifying base comprising (a) 20-60% by weight of at least one ester of pentaerythritol, dipentaerythritol and / or tripentaerythritol according to one of Claims 2 to 5 (b) 20-60% by weight. at least one partial glyceride according to one of claims 6 to 8 and (c) 5-30% by weight, preferably 10-30% by weight of at least one additional emulsifier selected from the group of anionic or nonionic emulsifiers with an HLB value greater 10 use, the self-emulsifying mixture contains less than 20 wt .-% water.
  • the percentages by weight relate to the amount of active substance in the self-emulsifying composition.
  • a water content of less than 15 wt .-%, in particular of less than 1O is "wt.%”.
  • the anionic emulsifier is selected from among the alkali metal salts of C12-C24-acyl glutamates.
  • Alkali metal salts of C16-C24 acylglutamates, alkali metal salts and triethanolamine salts of C16-C24 fatty acids and alkali metal salts of C16-C24 fatty alcohol (ether) sulfates or C16-C24 fatty alcohol (ether) phosphates are particularly preferred.
  • Alkali metal salts of C16-C18 acylglutamates, alkali metal and triethanolamine salts of C16-C18 fatty acids and alkali metal salts of C16-C18 fatty alcohol (ether) sulfates or of C 16-C 18 fatty alcohol (ether) phosphates are very particularly preferred.
  • acylglutamates are e.g. B. under the name Amisoft® from Ajinomoto in the trade.
  • Amisoft® HS-21 P diisodium stearoyl glutamate
  • Amisoft® HS-11 P sodium stearoyl glutamate
  • Soaps which are preferably suitable according to the invention contain palmitic and stearic acid in a weight ratio of 1: 3 to 3: 1.
  • a further preferred embodiment of the self-emulsifying base is characterized in that the nonionic emulsifiers with an HLB value greater than 10 are selected from the group of the C12-C24 fatty alcohol ethoxylates and / or the C12-C24 alkyl oligoglycosides.
  • usable C12-C24 fatty alcohol ethoxylates include, for example ceteareth-12, ceteareth-20, ceteareth-30 by Cognis Germany GmbH & Co. KG under the name Eumulgin ® B1, Eumulgin ® B2 or Eumulgin ® B3 in Are trade.
  • the C12-C24-alk (en) yl oligoglycosides which can preferably be used according to the invention are known nonionic surfactants which follow the formula (I), R 1 0- [G] p (I), in which R 1 is a C12-C24-alk (en) yl residue, G stands for a sugar residue with 5 or 6 carbon atoms and p stands for numbers from 1 to 10. They can be obtained according to the relevant procedures in preparative organic chemistry. As representative of the extensive literature, reference is made here to EP 0301298 A1 and WO 90/03977 A.
  • the alk (en) yl oligoglycosides can be derived from aldoses or ketoses with 5 or 6 carbon atoms, preferably glucose.
  • the preferred alk (en) yl oligoglycosides are thus alk (en) yl oligoglucosides.
  • the value p for a certain alk (en) yl oligoglycoside is an analytically determined arithmetic parameter, which usually represents a fractional number.
  • Alk (en) yl oligoglycosides with an average degree of oligomerization p of 1.1 to 3.0 are preferably used. From an application point of view, alk (en) yl oligoglycosides are preferred whose degree of oligomerization is less than 1.7 and in particular between 1.2 and 1.4.
  • alkyl oligoglycosides in which the radical R 1 is derived from primary, preferably unbranched, alcohols having 12 to 24 carbon atoms, in particular 16 to 24 and particularly preferably 16 to 18 carbon atoms.
  • Particularly preferred alkyl oligoglucosides are called Plantacare® 1200, - 2000, - 810, - 818, Tego Care® CG 90, Emulgade® PL 68/50, Montanov® 14, - 202, - 68, - 82, - L, - S, W018, Oramix® BG 14, -CG 110, -NS 10 offered in the market.
  • the wax mixtures according to the invention and the self-emulsifying bases are used for the production of cosmetic and pharmaceutical compositions.
  • the invention therefore furthermore relates to cosmetic or pharmaceutical preparations containing 1 to 20% by weight of a wax mixture according to the invention or 1 to 20% by weight of a self-emulsifying base according to the invention.
  • the use concentration is preferably 2-10% by weight.
  • the application also relates to the use of a wax mixture according to one of claims 1 to 7 for increasing the viscosity of emulsions, in particular oil-in Water emulsions, and the use of a self-emulsifying mixture according to one of claims 8 to 11 for increasing the viscosity of emulsions, in particular oil-in-water emulsions.
  • Another object of the application is the use of a wax mixture according to one of claims 1 to 7 or a self-emulsifying mixture according to one of claims 8 to 11 as a consistency agent in cosmetic or pharmaceutical emulsions.
  • lotions or creams are created, which are characterized by this; that there is an average particle size of 1 ⁇ m to 20 ⁇ m, preferably 5 ⁇ m to 10 ⁇ m.
  • the viscosities of such emulsions are between 2000 mPa-s and 500000 mPa-s, a range from 10000 mPa-s to 200000 mPa-s is preferred.
  • the viscosity measurements were carried out with a Brookfield RVF at 23 ° C ' Independent of the viscosity, the spindles 5 or 6 at 10 rpm (up to 60,000 mPa-s for lotions) or the spindle TE with Helipath (> 60,000 mPa-s for creams) were used.
  • the preparations according to the invention contain an aqueous and an oil phase, which can contain auxiliaries and additives.
  • the proportion of the water phase is usually in the range from 20-90% by weight, based on the overall composition, and the proportion of the oil phase is 1-70% by weight, based on the total composition.
  • the oil phase can be composed of an oil component or any mixture of oil components.
  • the oil component (s) is / are preferably present in an amount of 1-25% by weight, in particular 1-20% by weight and very preferably 5-15% by weight, based on the total composition.
  • the following classes of compounds are suitable as oil bodies, for example: Guerbet alcohols based on fatty alcohols with 6 to 18, preferably 8 to 10 carbon atoms in question, esters of linear or branched, saturated or unsaturated C6-C22 fatty acids with linear or branched, saturated or unsaturated C6-C22 fatty alcohols, especially 2-ethylhexanol.
  • esters are, for example, esters of C18-C38-alkylhydroxycarboxylic acids with linear or branched, saturated or unsaturated C6-C22-fatty alcohols, esters of linear and / or branched, saturated or unsaturated fatty acids with polyhydric alcohols (such as propylene glycol, dimer diol or trimer triol) and / or Guerbet alcohols
  • Cetiol® CC Guerbet carbonates based on fatty alcohols with 6 to 18, preferably 8 to 10 C atoms, esters of benzoic acid with linear and / or branched C6-C22 alcohols (e.g. Finsolv® TN) , linear or branched, symmetrical or asymmetrical dialkyl ethers having 6 to 22 carbon atoms per alkyl group, such as. B.
  • Di-n-octyl ether (Cetiol® OE) or ring opening products of epoxidized fatty acid esters with polyols, Kohlenwas5jers e_-JwJe_P.araffin --_ oder- mineral oils, _-- oligo- or eolyalphaolefins.
  • Dialkyl ethers, dialkyl carbonates, triglyceride mixtures and esters of C8-C24 fatty acids and C8-C24 fatty alcohols or a mixture of these substances are particularly suitable according to the invention as oil bodies.
  • the dialkyl carbonates and dialkyl ethers can be symmetrical or asymmetrical, branched or unbranched, saturated or unsaturated and can be prepared by reactions which are well known from the prior art.
  • Suitable silicone compounds are, for example, dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones (cyclomethicone) and amino, fatty acid, alcohol, polyether, epoxy, fluorine, glycoside and / or alkyl-modified silicone compounds.
  • Simethicones which are. Mixtures of dimethicones with an average chain length of 200 to 300 dimethylsiloxane units and hydrogenated silicates.
  • hydrocarbons preferably with a chain length of 8 to 40 carbon atoms
  • hydrocarbons can also be used as oil bodies. They can be branched or unbranched, saturated or unsaturated. Among them, branched, saturated C8-C40 alkanes are preferred. Both pure substances and mixtures of substances can be used. Usually it is a matter of mixtures of substances of different isomeric compounds. Compositions which have alkanes with 10 to 30, preferably 12 to 20, and particularly preferably 16 to 20 carbon atoms are particularly suitable, and among these a mixture of alkanes which contains at least 10% by weight of branched alkanes, based on the total amount of Contains alkanes. They are preferably branched, saturated alkanes.
  • auxiliaries and additives may include, for example, thickeners, superfatting agents, stabilizers, polymers, lecithins, phospholipids, biogenic agents, UV protection factors, antioxidants, deodorants; - film formers, - swelling agents; - insect repellents; Hydrotropes, solubilizers, preservatives, perfume oils, dyes etc., which are listed below as examples.
  • Suitable thickening agents are, for example, Aerosil types (hydrophilic silicas), polysaccharides, in particular xanthan gum, guar guar, agar agar, .alginate and unavoidable, carboxymethyl cellulose and hydroxyethyl and hydroxypropyl cellulose, polyvinyl alcohol, Polyvinyl pyrrolidone and bentonites such as e.g. B. Bentone® Gel VS-5PC (Rheox).
  • Aerosil types hydrophilic silicas
  • polysaccharides in particular xanthan gum, guar guar, agar agar, .alginate and unavoidable, carboxymethyl cellulose and hydroxyethyl and hydroxypropyl cellulose, polyvinyl alcohol, Polyvinyl pyrrolidone and bentonites such as e.g. B. Bentone® Gel VS-5PC (Rheox).
  • UV light protection factors are to be understood, for example, liquid or crystalline organic substances (light protection filters) at room temperature which are able to absorb ultraviolet rays and absorb the energy in the form of longer-wave radiation, e.g. B. to release heat again.
  • UV-B filters can be oil-soluble or water-soluble.
  • Derivatives of benzoylmethane are particularly suitable as typical UV-A filters.
  • the UV-A and UV-B filters can of course also be used in mixtures, for example combinations of the derivatives of benzoylmethane, e.g. B.
  • insoluble light-protection pigments namely finely dispersed metal oxides
  • suitable metal oxides are, in particular, zinc oxide and titanium dioxide.
  • secondary light stabilizers of the antioxidant type which interrupt the photochemical reaction chain which is triggered when UV radiation penetrates the skin.
  • biogenic active substances are tocopherol, tocopherol acetate, tocopherol palmitate, ascorbic acid, (deoxy) ribonucleic acid and its fragmentation products, ⁇ -glucans, retinol, Bisabolol, allantoin, phytantriol, panthenol, AHA acids, amino acids, ceramides, pseudoceramides, essential oils, plant extracts, such as. B. Prunus extract, Bambaranus extract and vitamin complexes to understand.
  • Deodorising actives counteract body odors, mask or eliminate them.
  • Body odors arise from the action of skin bacteria on apocrine sweat, whereby - unpleasant smelling degradation products are formed.
  • suitable deodorising agents include germ inhibitors, enzyme inhibitors, odor absorbers or odor maskers.
  • Suitable insect repellents are, for example, include N, N-diethyl-m-toluamide, 1, 2-diol or 3- (N-n-butyl-N-acetyl-amino) -propionic acid ethyl ester) which lent as Insect Repel- ® 3535 is marketed by Merck KGaA, as well as butylacetylaminopropionate.
  • Dihydroxyacetone is suitable as a self-tanner.
  • Arbutin, ferulic acid, kojic acid, coumaric acid and ascorbic acid (vitamin C) can be used as tyrosine inhibitors, which prevent the formation of melanin and are used in depigmenting agents.
  • Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid as well as the silver complexes known under the name Surfacine® and the other classes of substances listed in Appendix 6, Parts A and B of the Cosmetics Ordinance.
  • Perfume oils include mixtures of natural and synthetic fragrances. Natural fragrances are extracts of flowers, stems and leaves, fruits, fruit peels, roots, woods, herbs and grasses, needles and branches, resins and balms. Animal raw materials such as civet and castoreum and synthetic fragrance compounds of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type are also suitable.
  • the dyes which can be used are those which are suitable and approved for cosmetic purposes. Examples are Kochillerot A (Cl 16255), Patent Blue V (C.1.42051), Indigotine (C.1.73015), Chlorophyllin (C.1.75810), Quinoline Yellow (CI47005), Titanium Dioxide (C.1.77891), Indanthrene Blue RS (Cl 69800) and Madder varnish (CI58000). These dyes are usually used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.
  • the production (based on a 200g laboratory batch) takes place in the hot process. To do this, the oil phase is heated to 80 ° C. The water phase, also at 80 ° C, is slowly added to the oil phase with stirring. The emulsion is cooled to 40 ° C. with constant stirring. At 40 ° C, the pH is adjusted to 7, if necessary with citric acid or sodium hydroxide, and cooling to 30 ° C ' homogenized for 2 minutes using a suitable rotor-stator system (e.g. Ultra Turrax T 50 from IKA).
  • a suitable rotor-stator system e.g. Ultra Turrax T 50 from IKA.
  • the viscosity (Brookfield RVF, spindle 5, 10 rpm, 23 ° C.) of the emulsions produced in this way was determined after preparation and after 4, 8 and 12 weeks (W) and compared in the tables below.
  • the viscosity measurements were carried out at room temperature.
  • the amounts given below relate to% by weight of the commercially available substance in the overall composition.
  • the examples marked with “V” serve for comparison. It can clearly be seen that only the wax mixtures according to the invention have sufficient viscosity stability or phase stability in the monitoring period.
  • Emulsifier sodium stearoyl glutamate (mono salt) - anionic
  • Emollient Cococaprylate / Caprat - medium polar
  • esters of pentaerythritol obtained by reacting 1 mole of pentaerythritol with about 2 moles of a fatty acid mixture of 42-48 wt .-% C16 fatty acid ⁇ and 50-56 wt .-% of C18 fatty acid (residual amounts: ⁇ C14 Fatty acids and> C18 fatty acids) is obtained and has the following ester distribution: 12-19% by weight monoester, (b) 25-35% by weight diester, (c) 30-40% by weight triester and ⁇ (i.e. ) Contains 6-11% by weight tetraester and less than 0.3% by weight C17 fatty acid acyl groups. This ester was also used in all other experiments (see the following tables).
  • Emulsifier sodium cetearyl sulfate - anionic
  • Emollient cococaprylate / caprate - medium polar
  • Emulsifier lauryl glucoside - non-ionic
  • Emollient Cococaprylate / Caprat - medium polar

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
EP05716400A 2004-04-05 2005-03-26 Wachmischung auf basis von partialglyceriden und pentaerythritestern Withdrawn EP1750659A1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102004017222A DE102004017222A1 (de) 2004-04-05 2004-04-05 Sensorische Wachse für kosmetische und/oder pharmazeutische Formulierungen
DE200410031939 DE102004031939A1 (de) 2004-06-30 2004-06-30 Wachsmischung auf Basis von Partialglyceriden und Pentaerythritestern
DE102004039471 2004-08-14
PCT/EP2005/003233 WO2005097056A1 (de) 2004-04-05 2005-03-26 Wachmischung auf basis von partialglyceriden und pentaerythritestern

Publications (1)

Publication Number Publication Date
EP1750659A1 true EP1750659A1 (de) 2007-02-14

Family

ID=34962514

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05716400A Withdrawn EP1750659A1 (de) 2004-04-05 2005-03-26 Wachmischung auf basis von partialglyceriden und pentaerythritestern

Country Status (4)

Country Link
US (1) US20080249192A1 (enExample)
EP (1) EP1750659A1 (enExample)
JP (1) JP2007531777A (enExample)
WO (1) WO2005097056A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2233154A4 (en) * 2007-12-07 2016-01-06 Shiseido Co Ltd EXTERNAL SKIN PREPARATION

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006027151A1 (de) * 2004-09-06 2006-03-16 Schwan-Stabilo Cosmetics Gmbh & Co. Kg Zubereitung, insbesondere kosmetische zubereitung, verfahren zu ihrer herstellung und ihre verwendung
DE102005020583B4 (de) * 2004-09-06 2016-02-18 Schwan-Stabilo Cosmetics Gmbh & Co. Kg Zubereitung, insbesondere kosmetische Zubereitung sowie ihre Verwendung
KR101031568B1 (ko) * 2008-05-28 2011-05-04 가부시키가이샤 분쵸우 투명 고형상 마카
JP4646269B2 (ja) 2009-03-31 2011-03-09 株式会社資生堂 皮膚外用剤
FR2944958B1 (fr) * 2009-04-30 2011-07-08 Oreal Emulsion cire-dans-eau comprenant l'association d'un derive d'acide glutamique et d'un alkylpolyglycoside
EP2467132B1 (en) 2009-12-31 2016-10-19 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
US11071878B2 (en) 2009-12-31 2021-07-27 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
EP2366377B1 (de) * 2010-03-16 2013-12-04 Cognis IP Management GmbH Konditionierungsmittel und konditionierende Shampoo-Zusammensetzung enthaltend Pentaerythrit-Ester
ES2786103T3 (es) 2011-06-29 2020-10-08 Sol Gel Tech Ltd Formulaciones tópicas estabilizadas que contienen microcápsulas de núcleo-cubierta
DE102013208880A1 (de) * 2013-05-14 2014-11-20 Beiersdorf Ag Stabilisierte Zubereitungen mit einem Gehalt an Ascorbinsäure und Gemischen aus Natriumstearoylglutamat und/oder Cetylstearylsulfat in Kombination mit Glycerylstearat
DE102014223570A1 (de) * 2014-11-19 2016-05-19 Beiersdorf Ag Zubereitungen mit einem Gehalt an Ascorbinsäure, Ubidecarenon und Phosphationen zur verbesserten Hautkonturierung bzw. gegen Cellulite
DE102014223568A1 (de) * 2014-11-19 2016-05-19 Beiersdorf Ag Zubereitungen mit einem Gehalt an Ascorbinsäure, Ubidecarenon und Gemischen aus Natriumstearoylglutamat und/oder Cetylstearylsulfat in Kombiantion mit Glycerylstearat
HRP20251185T1 (hr) 2017-07-12 2025-11-21 Sol-Gel Technologies Ltd. Tvari koje obuhvaćaju tretinoin u kapsulama
FR3133617B1 (fr) 2022-03-15 2025-02-21 Gattefosse Sas Utilisation comme base émulsionnante dans une formulation cosmétique ou pharmaceutique, d’une composition comprenant du stéaroyl glutamate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3131006A1 (de) * 1981-08-05 1983-02-24 Henkel Kgaa "cremegrundlage"
JPH0662382B2 (ja) * 1984-10-22 1994-08-17 株式会社コーセー 長もちする化粧品組成物
DE3723826A1 (de) * 1987-07-18 1989-01-26 Henkel Kgaa Verfahren zur herstellung von alkylglykosiden
US5576425A (en) * 1988-10-05 1996-11-19 Henkel Kommanditgesellschaft Auf Aktien Process for the direct production of alkyl glycosides
DE19828081C2 (de) * 1998-06-24 2000-08-10 Cognis Deutschland Gmbh W/O-Emulsionsgrundlagen
DE10034619A1 (de) * 2000-07-17 2002-01-31 Cognis Deutschland Gmbh Aniontensidfreie niedrigviskose Trübungsmittel
DE10143960A1 (de) * 2001-09-07 2003-03-27 Basf Ag Kosmetische und dermatologische Zubereitungen in Stiftform, enthaltend ein aminosubstituiertes Hydroxybenzophenon
JP2005508919A (ja) * 2001-09-29 2005-04-07 バイヤースドルフ・アクチエンゲゼルシヤフト 化粧用および皮膚科学用スティック
EP1374846A1 (de) * 2002-06-19 2004-01-02 Cognis Iberia, S.L. Hochviskose ölhaltige Zubereitungen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2005097056A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2233154A4 (en) * 2007-12-07 2016-01-06 Shiseido Co Ltd EXTERNAL SKIN PREPARATION

Also Published As

Publication number Publication date
WO2005097056A1 (de) 2005-10-20
US20080249192A1 (en) 2008-10-09
JP2007531777A (ja) 2007-11-08

Similar Documents

Publication Publication Date Title
EP0582246B1 (de) Polyglycerinfettsäureestergemisch
EP1742607B1 (de) O/w-gel-zusammensetzungen mit estern des pentaerythrits oder dessen oligomeren
EP1750659A1 (de) Wachmischung auf basis von partialglyceriden und pentaerythritestern
EP1732877B1 (de) Sensorische wachse für kosmetische und/oder pharmazeutische formulierungen
EP1028703B1 (de) Wässrige kosmetische zubereitungen in stiftform
DE3010879A1 (de) Emulgator-zusammensetzung
EP1853219B1 (de) Emollients und kosmetische zusammensetzungen auf basis spezieller verzweigter kohlenwasserstoffe
EP1773283B1 (de) Hochkonzentrierte, selbstemulgierende emulsionsgrundlagen zur herstellung von öl in wasser emulsionen
EP2144597B1 (de) Wirkstoff-stabilisierende o/w-emulsionen ii
EP1512392B1 (de) Emollient Mischung für kosmetische Formulierungen
EP1888219B1 (de) Emulgatorzusammensetzung auf basis von pentaerythritestern und alkoxylierten nichtionischen emulgatoren
DE19624455C2 (de) Sonnenschutzmittel in Form von O/W-Mikroemulsionen
EP2206489A1 (de) Fließfähige Emulsionskonzentrate
WO2005107681A1 (de) Emulgatorkonzentrat für kosmetische zusammensetzung
WO2008135187A1 (de) Kosmetische zusammensetzungen enthaltend ester auf basis von 2-propylheptansäure
DE102004031939A1 (de) Wachsmischung auf Basis von Partialglyceriden und Pentaerythritestern
DE19540831C2 (de) Kosmetische und pharmazeutische Emulsionen
DE19548345C2 (de) Verwendung von Mischungen spezieller Emulgatoren und Ölkörpern
EP1593370A1 (de) Glycerinethergemisch, dieses enthaltende kosmetische Zusammensetzung sowie Verfahren zu dessen Herstellung
EP3285732A1 (de) Isosorbiddiester als perlglanzmittel und trübungsmittel
DE19643063A1 (de) Kosmetische Zubereitungen in Stiftform
DE102005061239A1 (de) Emollient Mischung für kosmetische und pharmazeutische Formulierungen
EP3302714B1 (de) Kombination von isosorbiddiestern mit nichtionischen tensiden als perlglanzmittel
DE29520749U1 (de) Kosmetische und pharmazeutische Emulsionen
DE29520751U1 (de) Kosmetische und pharmazeutische Emulsionen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060926

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE ES FR GB IT

RIN1 Information on inventor provided before grant (corrected)

Inventor name: GOGET, CAROLINE

Inventor name: ISSBERNER, ULRICH

Inventor name: MITCHELL, CATHERINE

Inventor name: KAWA, ROLF

DAX Request for extension of the european patent (deleted)
RBV Designated contracting states (corrected)

Designated state(s): DE ES FR GB IT

17Q First examination report despatched

Effective date: 20090119

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100928